Posted by Michael Wonder on 17 May 2025
PharmaTher announces FDA extends review period for ketamine; new approval goal date 9 August 2025
16 May 2025 - PharmaTher today announced the US FDA has extended the approval goal date for the review of its new drug application for ketamine.
The new approval goal date is 9 August 2025, revised from the previous date of 4 June 2025.
